What should I do if I experience itching while taking Macrobid (nitrofurantoin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Itching While Taking Macrobid (Nitrofurantoin)

If you experience itching while taking Macrobid (nitrofurantoin), you should contact your healthcare provider immediately as this may represent a hypersensitivity reaction requiring medication discontinuation and alternative treatment.

Understanding Nitrofurantoin-Associated Pruritus

Pruritus (itching) is a documented adverse effect of nitrofurantoin listed in the FDA drug label. It can occur with or without visible skin changes and may represent an allergic reaction to the medication 1. Nitrofurantoin can cause several types of dermatologic reactions, ranging from mild pruritus to more severe reactions such as:

  • Simple pruritus without rash
  • Urticaria (hives)
  • Maculopapular or erythematous eruptions
  • More severe reactions like exfoliative dermatitis or erythema multiforme (including Stevens-Johnson syndrome)

Assessment Algorithm

  1. Evaluate severity of itching:

    • Mild (localized, intermittent)
    • Moderate (widespread, intermittent, limiting instrumental activities)
    • Severe (intense, widespread, constant, limiting self-care)
  2. Check for accompanying symptoms:

    • Presence of rash, hives, or skin changes
    • Respiratory symptoms (cough, dyspnea)
    • Fever or chills
    • Angioedema (swelling of face, lips, tongue)
  3. Determine timing of symptom onset:

    • Within first week (more likely acute hypersensitivity)
    • After prolonged use (may indicate developing chronic reaction)

Management Recommendations

For Mild Isolated Pruritus (without rash or other symptoms):

  1. Contact your healthcare provider to report the symptom

  2. Apply topical treatments:

    • Moderate to high-potency topical corticosteroids to affected areas 2, 3
    • Moisturizing lotions for dry skin 2
  3. Consider oral antihistamines:

    • Non-sedating antihistamines (loratadine 10 mg daily) during daytime 2, 3
    • Sedating antihistamines (diphenhydramine 25-50 mg or hydroxyzine 25-50 mg) at night if sleep is affected 2, 3
  4. Reassess after 48-72 hours:

    • If improving, continue symptomatic treatment
    • If worsening or not improving, proceed to next steps

For Moderate to Severe Pruritus or Any Pruritus with Additional Symptoms:

  1. Stop taking nitrofurantoin immediately and contact healthcare provider urgently 2, 1

  2. Seek medical evaluation to determine if this represents a true drug allergy or severe reaction

  3. Alternative antibiotic therapy will likely be needed to treat the underlying urinary tract infection

  4. Document the reaction in your medical record to avoid future exposure

Important Considerations

  • Risk factors for nitrofurantoin reactions: Elderly patients, those with renal impairment, and patients with previous drug allergies may be at higher risk 4, 5

  • Monitoring: Be vigilant for signs of more serious reactions, particularly respiratory symptoms, as nitrofurantoin can cause pulmonary toxicity 1, 4

  • Documentation: If you experience a significant reaction to nitrofurantoin, ensure it's documented in your medical records and consider carrying written information about this allergy 4

  • Alternative treatments: Several other antibiotics can effectively treat urinary tract infections if nitrofurantoin cannot be continued 6, 5

When to Seek Emergency Care

Seek immediate medical attention if you experience:

  • Difficulty breathing
  • Swelling of face, lips, tongue or throat
  • Severe skin reactions (blistering, peeling)
  • High fever
  • Severe dizziness

Remember that while nitrofurantoin is effective for treating UTIs, patient safety takes priority when adverse reactions occur. The British Association of Dermatologists guidelines recommend that medication cessation should be undertaken if the risk-benefit analysis favors discontinuation 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Isolated Pruritus after Vancomycin and Cefepime Initiation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin pulmonary toxicity.

The Journal of family practice, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.